Characteristics of the patients | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Sr. No | Sample ID | Methylation array | GE array | Rai stage | Age | Tumor Percentage | IGHV status | β2M(mg/L) | 17p Deletion | IPI Score |
1 | S1 | √ |  | 0 | 41 | 67.2 | UM | 6.56 | Absent | 4 |
2 | S2 | √ | √ | 0 | 63 | 69 | UM | 4.06 | Absent | 4 |
3 | S3 | √ | √ | 0 | 69 | 88.6 | UM | 8.42 | Absent | 5 |
4 | S4 | √ | √ | I | 45 | 95.4 | UM | 4.6 | Present | 9 |
5 | S5 | √ | √ | I | 60 | 93.5 | UM | 3.37 | Absent | 3 |
6 | S6 | √ | √ | II | 50 | 66 | UM | 4.78 | Absent | 5 |
7 | S7 | √ |  | II | 59 | 97.2 | M | 3.54 | Absent | 3 |
8 | S8 | √ |  | 0 | 57 | 95.3 | M | 6.49 | Absent | 2 |
9 | S9 | √ |  | II | 65 | 92.8 | M | 4.58 | Absent | 3 |
10 | S10 | √ | √ | 0 | 61 | 69.3 | M | 3.3 | Absent | 0 |
11 | S11 | √ | √ | II | 65 | 97.2 | M | 4.48 | Present | 7 |
12 | S12 | √ | √ | II | 67 | 98 | UM | 5.69 | Absent | 6 |
13 | S13 | √ | √ | II | 48 | 92 | UM | 4.42 | Absent | 5 |
14 | S14 | √ |  | I | 58 | 95.62 | UM | 6.31 | Absent | 5 |
15 | S15 |  | √ | I | 46 | 79.4 | UM | 6.78 | Absent | 5 |
16 | S16 |  | √ | II | 59 | 73 | UM | 4.43 | Absent | 5 |
17 | S17 |  | √ | I | 40 | 90 | UM | 7.74 | Absent | 5 |
18 | S18 |  | √ | I | 67 | 79.3 | UM | 2.59 | Absent | 4 |
19 | S19 |  | √ | I | 51 | 80 | M | 5.44 | Absent | 3 |
20 | S20 |  | √ | 0 | 57 | 72.5 | M | 2.91 | Absent | 0 |
21 | S21 |  | √ | II | 65 | 68.6 | M | 7.1 | Absent | 2 |
22 | S22 |  | √ | II | 52 | 66 | M | 3.2 | Absent | 1 |
23 | S23 |  | √ | I | 60 | 92 | M | 6.56 | Absent | 3 |
24 | S24 |  | √ | I | 44 | 85.1 | M | 3.62 | Absent | 3 |
25 | S25 |  | √ | II | 68 | 93 | M | 6.47 | Absent | 4 |
26 | S26 |  | √ | II | 80 | 68.4 | M | 6.46 | Absent | 4 |